Neogen Chemicals Ltd.

Neogen Chemicals Ltd.

2,239.20
INR
-120.70
(-5.11%)
13.39EPS
151.26P/E
55.45BMarket Cap
Nov 09Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
36.76
41.79
49.95
54.82
80.58
119.06
131.19
144.17
190.44
264.83
262.66
286.54
321.56
348.43
Basic EPS, GAAP
1.81
2.53
2.58
3.83
5.49
10.43
12.28
13.43
17.9
20.04
13.96
13.2
10.9
13.39
Free Cash Flow per Basic Share
1.46
4.27
4.01
-0.06
5.92
-11.86
-27.16
-22.06
-67.71
-53.77
-129.96
-46.14
-298.39
- -
Dividend per Share
0.45
0.45
0.51
0.19
1.59
1.87
1.84
2
2.11
2.75
2.93
2
1
- -
Book Value per Share
9.76
11.7
13.72
21.03
25.11
34.96
66.96
78.43
176.16
193.48
288.19
299.22
309.41
- -
Tangible Book Value per Share
9.75
11.69
13.72
21.03
25.08
34.91
66.82
78.29
176.09
192.91
287.75
298.87
309.17
- -
Basic Weighted Avg Shares
20
20
20
20
20
20
23
23
25
25
26
26
26
27
Sales/Revenue/Turnover
738
839
1,003
1,101
1,612
2,391
3,061
3,364
4,749
6,605
6,708
7,559
8,483
9,255
Operating Margin (%)
14.38
13.97
13.69
17.15
16.84
17.15
17.25
16.99
15.77
14.45
13
14.47
12.96
13.48
Depreciation Expense
9
9
10
13
19
28
52
69
117
162
229
278
275
299
Net Income, GAAP
36
51
52
77
110
209
287
313
446
500
357
348
288
356
Effective Tax Rate (%)
41.14
36.95
38.92
33.23
36.96
28.4
30.27
29.13
21.8
29.65
32.44
30.56
30.01
28.94
Profit Margin (%)
4.94
6.06
5.16
6.98
6.82
8.76
9.36
9.31
9.4
7.57
5.31
4.61
3.39
3.84
Working Capital
94
151
153
231
232
430
812
622
2,742
2,461
2,567
2,664
2,048
- -
LT Debt
48
47
48
368
385
506
375
1,178
1,235
1,341
1,377
1,939
8,681
- -
Total Equity
196
235
275
422
504
702
1,562
1,830
4,393
4,825
7,603
7,894
8,163
- -
Return on Invested Capital (%)
- -
15.46
16.08
15.04
13.85
18
14.95
11.47
10.91
8.82
5.8
5.1
4.25
- -
Return on Capital (%)
- -
16.96
15.23
14.64
14.1
17.97
14.79
11.48
10.92
8.77
6.05
4.78
3.97
- -
Return on Common Equity (%)
- -
23.61
20.3
22.02
23.71
34.73
25.31
18.47
14.34
10.84
5.74
4.5
3.58
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
5,270
- -
LT Borrowings
- -
8,192
- -
LT Finance Leases
- -
489
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
26
26
27
Market Capitalization
31,241
29,336
55,445

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
13,925
- -
Cash, Cash Equivalents & STI
- -
2,912
- -
Accounts Receivable, Net
- -
3,804
- -
Inventories
- -
5,682
- -
Total Current Liabilities
- -
11,877
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
5,270
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
46.63%
42.93%
3.4%
Free Cash Flow
-915.03%
167.68%
546.68%
Net Income, GAAP
23.41%
1.2%
-17.46%
Sales/Revenue/Turnover
24.92%
21.35%
12.22%
Total Cash Common Dividend
68.11%
-5.46%
-50%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1,800
1,934
2,014
2,028
7,559
2026
1,867
2,087
2,200
2,466
8,483
2027
2,503
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
4.35
4.15
3.8
0.91
13.2
2026
3.89
1.28
1.4
4.32
10.9
2027
6.29
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
2
2026
- -
- -
- -
- -
1
2027
- -
- -
- -
- -
- -

Company Description

CEO
Harin Haridas Kanani
Full Time Employees
989
Sector
Process industries
Industry
Chemicals: specialty
Address
Dev Corpora Building Thane MA India 400601
IPO Date
May 8, 2019
Business
Neogen Chemicals Limited, founded in 1989 and headquartered in Thane, Maharashtra, India, manufactures and exports bromine- and lithium-based specialty chemicals, including a broad range of organic and inorganic compounds such as lithium bromide, lithium chloride, lithium iodide, lithium sulphate, Grignard reagents, bromobenzene, 1,3-dibromopropane, and intermediates derived from bromination, alkylation, acylation, amination, oxidation, dehalogenation, silylation, Halex reaction, Friedel-Crafts, couplings, and chlorination chemistries; it also provides custom synthesis and contract manufacturing services for pharmaceutical, agrochemical, engineering, specialty polymers, photography, construction chemicals, and battery materials sectors. The company operates state-of-the-art manufacturing facilities in Mahape, Navi Mumbai (Maharashtra), Karakhadi, Vadodara (Gujarat), and Dahej SEZ, Bharuch (Gujarat), with exports to 29 countries across Europe, the USA, Middle East, Japan, and other regions. Recent developments include the May 2023 acquisition of BuLi Chemicals India Private Limited (merged effective April 2024), enhancing organolithium derivatives capacity; the incorporation of wholly-owned subsidiary Neogen Ionics Limited in March 2023 for lithium-ion battery electrolytes following a technology acquisition agreement with Japan-based MU Iconic Solutions Corporation; a August 2025 joint venture agreement between Neogen Ionics and Japan's Morita Chemicals Industries (via Morita Investment Limited) to form Neogen Morita New Materials Ltd. for producing solid LiPF6 electrolyte salts with a combined USD 20 million investment; a ₹1,500 crore capital expenditure plan through 2026 focused on battery chemicals, lithium salts, and electrolytes at Dahej expansions; and a July 2025 approval to raise up to ₹200 crore via non-convertible debentures.